MediciNova enters equity distribution agreement for up to $50M at-the-market offering

MEDICINOVA INC

Agreement with Lucid Capital Markets as sales agent for at-the-market sales of common stock.
Maximum aggregate offering price of $50,000,000 under the Sales Agreement.
Agent compensation set at 3.0% of gross sales price per share sold.
Company may suspend or terminate the agreement at any time; no obligation to sell shares.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.98

MEDICINOVA INC entered into Sales Agreement with Lucid Capital Markets, LLC valued at $50,000,000 (effective 2025-12-29).

Action: entry
Agreement: atm program
Counterparty: Lucid Capital Markets, LLC
Value: $50,000,000
Effective: 2025-12-29

Exact text from the filing

On December 29, 2025, MediciNova, Inc. (the “Company”) entered into an equity distribution agreement with Lucid Capital Markets, LLC (“Agent”) to sell shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), from time to time through the Agent, acting as sales agent, having a maximum aggregate offering price of $50,000,000 (the “Sales Agreement”).

View on SEC.gov

290 material agreements filed in the last 30 days. Browse all material agreements →

MEDICINOVA INC filing history →

Source: SEC EDGAR

accession 0001193125-25-335917

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.